New Method for RNA-Seq Helps Unravel Data from a Mixture of People

The technique could help study how genetic variants in different people affect which genes are expressed during infection or response to drugs ,and could also increase efficiency of single-cell experiments, assisting research into transplants, personalized medicine, and malaria.

Iceni Diagnostics Eyes Fall Release of At-Home Coronavirus Test

While the test, which exploits glycan biology to detect current infection with SARS-CoV-2 is undergoing clinical assessment, the company is working in parallel to ensure that mass production can be rolled out once validation is completed.

AMP Publishes Recommendations for Clinical Genotyping Tests to Predict Warfarin Response

The AMP PGx Working Group developed the guideline with organizational representation from the College of American Pathologists (CAP) and the Clinical Pharmacogenetics Implementation Consortium (CPIC).
Arrow going down and question mark and man stopping it

COVID-19 Precipitates Sharp Decline in Cancer Testing, Diagnoses

While the decrease was most pronounced in lung cancer testing and diagnoses, the oncology tracker also recorded reduced diagnosis rates in colorectal, ovarian, and breast cancers over the same period.
Abs COVID-19 structure

NIH Launches $1.5B Rapid COVID-19 Testing Technology Challenge

NIH is urging all scientists and inventors with a rapid testing technology to compete in a national COVID-19 testing challenge for a share of up to $500 million over all phases of development.
Biocept intends to become Thermo Fisher Scientific’s “Center of Excellence” for oncology-focused liquid biopsy efforts as part of a commercial collaboration by the companies. [© AlexRaths/iStock]

Largest Real-World ctDNA Study Doubles Detection of New Cancers

The DETECT-A study was the largest liquid biopsy study in a general population with no history of the disease. Together, the blood test plus standard-of-care testing had a combined sensitivity of 52.1%, double the rate of standard screening alone.

Rare Gene Discovered That Nearly Doubles Risk of Developing a Neurodegenerative Disease

The researchers found that rare variation in the gene TET2 nearly doubled the risk of developing diseases like Alzheimer disease (AD), amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD).
DNA saliva collection tube

Sensitive and Consistent SARS-CoV-2 Detection via Saliva Samples

Using saliva for COVID-19 testing has several advantages when compared to collection of nasopharyngeal swabs: it does not require specialized swabs or tubes, is far less uncomfortable for the patient, and may even be done independently by the patient.

Portable Coronavirus Test Developed Using Microfluidics and a Cell Phone

The platform comprises a cartridge-housed microfluidic chip that carries out isothermal amplification of viral nucleic acids from nasal swab samples, which are then detected using the smartphone camera.
Illustration of the lungs

Veracyte Gets Exclusive License to IPF Gene Signature from Yale

Veracyte plans to make the non-invasive, blood-based test available as a complement to its Envisia Genomic Classifier to aid in the diagnosis and treatment of patients with IPF.
Scroll Up